The silent epidemic: Unmasking the global impact of non-adherence
As the lead author of the OECD’s 2018 milestone report on adherence1, Rabia Khan discussed in her session how medication non-adherence remains a significant and overlooked global health challenge impacting millions, leading to poor health outcomes and increased healthcare costs. Despite efforts to address this issue over the past 20 years, the problem persists, with high rates of patients not filling prescriptions, discontinuing medications, and not taking them as prescribed. This presentation explores the size and impact of non-adherence, pointing out its critical importance in the post-COVID-19 era, marked by mistrust and misinformation, and calls for a collective effort to overcome these challenges.
If you want to learn more about the silent challenge of non-adherence and how to rebuild trust in healthcare providers to improve patient outcomes and reduce costs, watch the video.
1. Khan R and Socha-Ditrich K. Investing in medication adherence improves health outcomes and health system efficiency. Adherence to medicines for diabetes, hypertension, and hyperlipidaemia. OECD health working paper No. 105, OECD publishing Paris. 2018.
Speakers
Ms. Rabia
Khan
Australia
